Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $320,876 - $349,191
-3,203 Reduced 56.16%
2,500 $272,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $268,596 - $298,286
-2,609 Reduced 31.39%
5,703 $587,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $468,326 - $510,454
4,312 Added 107.8%
8,312 $959,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $798,581 - $905,231
-9,565 Reduced 70.51%
4,000 $365,000
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $703,123 - $788,156
9,565 Added 239.13%
13,565 $1.11 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $21,684 - $27,162
-300 Reduced 6.98%
4,000 $307,000
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $89,518 - $105,443
1,300 Added 43.33%
4,300 $331,000
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $567,557 - $629,872
-7,908 Reduced 72.5%
3,000 $245,000
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $147,091 - $166,729
2,010 Added 22.59%
10,908 $905,000
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $415,337 - $472,606
5,898 Added 196.6%
8,898 $688,000
Q1 2019

May 06, 2019

SELL
$69.58 - $79.36 $139,160 - $158,720
-2,000 Reduced 40.0%
3,000 $250,000
Q2 2018

Jul 17, 2018

SELL
$50.83 - $59.72 $270,008 - $317,232
-5,312 Reduced 51.51%
5,000 $304,000
Q1 2018

Apr 18, 2018

BUY
$50.96 - $59.23 $23,135 - $26,890
454 Added 4.61%
10,312 $562,000
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $20,648 - $24,656
-400 Reduced 3.9%
9,858 $555,000
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $601,836 - $647,587
10,258
10,258 $657,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Alethea Capital Management, LLC Portfolio

Follow Alethea Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.